Resuscitative effect of centhaquin after hemorrhagic shock in rats
- PMID: 22964270
- DOI: 10.1016/j.jss.2012.08.042
Resuscitative effect of centhaquin after hemorrhagic shock in rats
Abstract
Background: Centhaquin is a cardiovascular active agent that significantly reduced blood lactate levels and enhanced resuscitative effect of hypertonic saline. The present study was carried out to determine the resuscitative effect of centhaquin and compare that with large-volume lactated Ringer (LR) solution in hemorrhaged rats.
Materials and methods: Male, adult Sprague-Dawley rats were anesthetized with urethane, and a pressure catheter SPR-320 was placed in the left femoral artery; another pressure-volume catheter SPR-869 was placed into the left ventricle through carotid artery. Hemorrhage was induced by withdrawing blood from the right femoral artery, and the mean arterial pressure (MAP) was maintained at 35 mm Hg for 30 minutes after which resuscitation was performed using LR solution (LR-100) (100% shed blood volume), centhaquin (0.017, 0.05, and 0.15 mg/kg) dissolved in LR (100% shed blood volume), or LR-300 (300% shed blood volume). Arterial blood gases and cardiovascular parameters were determined before the induction of hemorrhage and at various times after hemorrhage.
Results: It was found that survival time after resuscitation with LR-100 was 78 ± 10 min. Centhaquin in doses of 0.017 and 0.05 mg/kg significantly improved survival time to 291 ± 57 and 387 ± 39 min, respectively. Blood lactate levels (millimoles per liter) increased from 7.22 ± 0.67 at hemorrhage to 10.20 ± 0.61 at 60 min after resuscitation with LR-100. On the other hand, blood lactate levels significantly decreased to 3.55 ± 0.07 and 4.08 ± 0.28 at 60 min after resuscitation with 0.017 and 0.05 mg/kg doses of centhaquin, respectively. Centhaquin in these doses produced a 55% and 59% increase in MAP, respectively, compared with a 29% decrease by LR-100. A decrease in systemic vascular resistance of 57% and 41% was observed with 0.017 and 0.05 mg/kg doses of centhaquin, respectively, compared with a 6% decrease by LR-100. LR-100 decreased cardiac output (CO) by 28%, whereas 0.017 and 0.05 mg/kg doses of centhaquin increased it by 260% and 180%, respectively. LR-300 commonly used for resuscitation was found to increase MAP and CO. Compared with LR-300, centhaquin (0.05 mg/kg) significantly improved survival time, increased CO, and was effective in resuscitation of hemorrhaged rats.
Conclusions: Centhaquin was found to be more effective than LR-300 as an effective resuscitative agent for the treatment of hemorrhagic shock in rat.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Role of adrenergic receptors in shock.Front Physiol. 2023 Jan 16;14:1094591. doi: 10.3389/fphys.2023.1094591. eCollection 2023. Front Physiol. 2023. PMID: 36726848 Free PMC article. Review.
-
Centhaquin improves resuscitative effect of hypertonic saline in hemorrhaged rats.J Surg Res. 2012 Nov;178(1):415-23. doi: 10.1016/j.jss.2012.02.005. Epub 2012 Apr 2. J Surg Res. 2012. PMID: 22487389
-
Efficacy of centhaquin as a small volume resuscitative agent in severely hemorrhaged rats.Am J Emerg Med. 2013 Sep;31(9):1315-21. doi: 10.1016/j.ajem.2013.05.032. Epub 2013 Jul 19. Am J Emerg Med. 2013. PMID: 23871440
-
HSD is a better resuscitation fluid for hemorrhagic shock with pulmonary edema at high altitude.Shock. 2008 Dec;30(6):714-20. doi: 10.1097/SHK.0b013e31816f6b5b. Shock. 2008. PMID: 18461019
-
Titrated hypertonic/hyperoncotic solution for hypotensive fluid resuscitation during uncontrolled hemorrhagic shock in rats.Resuscitation. 2005 Apr;65(1):87-95. doi: 10.1016/j.resuscitation.2004.10.012. Resuscitation. 2005. PMID: 15797280
Cited by
-
Role of adrenergic receptors in shock.Front Physiol. 2023 Jan 16;14:1094591. doi: 10.3389/fphys.2023.1094591. eCollection 2023. Front Physiol. 2023. PMID: 36726848 Free PMC article. Review.
-
Pathophysiology of Hemorrhage as It Relates to the Warfighter.Physiology (Bethesda). 2022 May 1;37(3):141-153. doi: 10.1152/physiol.00028.2021. Epub 2022 Jan 10. Physiology (Bethesda). 2022. PMID: 35001653 Free PMC article. Review.
-
A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients.Drugs. 2021 Jun;81(9):1079-1100. doi: 10.1007/s40265-021-01547-5. Epub 2021 Jun 1. Drugs. 2021. PMID: 34061314 Free PMC article. Clinical Trial.
-
Centhaquine Restores Renal Blood Flow and Protects Tissue Damage After Hemorrhagic Shock and Renal Ischemia.Front Pharmacol. 2021 May 3;12:616253. doi: 10.3389/fphar.2021.616253. eCollection 2021. Front Pharmacol. 2021. PMID: 34012389 Free PMC article.
-
Resuscitative Effect of Centhaquine (Lyfaquin®) in Hypovolemic Shock Patients: A Randomized, Multicentric, Controlled Trial.Adv Ther. 2021 Jun;38(6):3223-3265. doi: 10.1007/s12325-021-01760-4. Epub 2021 May 10. Adv Ther. 2021. PMID: 33970455 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
